“The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.
The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the bioburden testing market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the bioburden testing market. The report analyzes the market by product, test type, application, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioburden testing market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the bioburden testing market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bioburden testing products across regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioburden testing market
”
“TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 MARKET STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN & DATA TRIANGULATION 23
2.3 KEY DATA FROM SECONDARY SOURCES 24
2.4 KEY DATA FROM PRIMARY SOURCES 25
2.5 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 32
4.1 BIOBURDEN TESTING CONSUMABLES MARKET 32
4.2 BIOBURDEN TESTING MARKET, BY PRODUCT 33
4.3 BIOBURDEN TESTING MARKET, BY TEST TYPE 35
4.4 BIOBURDEN TESTING MARKET, BY APPLICATION 36
4.5 GEOGRAPHICAL SNAPSHOT OF THE BIOBURDEN TESTING MARKET 37
4.6 BIOBURDEN TESTING MARKET, BY END USER 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET SEGMENTATION 40
5.2.1 BIOBURDEN TESTING MARKET, BY PRODUCT 40
5.2.2 BIOBURDEN TESTING MARKET, BY TEST TYPE 41
5.2.3 BIOBURDEN TESTING MARKET, BY APPLICATION 41
5.2.4 BIOBURDEN TESTING MARKET, BY END USER 42
5.2.5 BIOBURDEN TESTING MARKET, BY REGION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 44
5.3.1.1 Growth in the medical devices, pharmaceutical, and biotechnology industries 44
5.3.1.2 Increasing food & beverage safety concerns 44
5.3.1.3 Increasing product recalls due to microbial contamination 44
5.3.1.4 Growing healthcare industry and rising medical spending 44
5.3.2 RESTRAINTS 46
5.3.2.1 High cost of microbial enumeration instruments 46
5.3.3 OPPORTUNITIES 47
5.3.3.1 Increasing preference for contract manufacturing 47
5.3.3.2 Growth opportunities in emerging economies 47
5.3.4 CHALLENGES 48
5.3.4.1 Shortage of knowledgeable and skilled professionals 48
5.3.4.2 Stringent regulatory policies for instruments and consumables 48
6 INDUSTRY INSIGHT 50
6.1 PORTER’S FIVE FORCES ANALYSIS 50
6.1.1 THREAT OF NEW ENTRANTS 50
6.1.2 THREAT OF SUBSTITUTES 51
6.1.3 BARGAINING POWER OF BUYERS 51
6.1.4 BARGAINING POWER OF SUPPLIERS 51
6.1.5 INTENSITY OF RIVALRY 51
6.2 STRATEGIC BENCHMARKING 52
6.3 SUPPLY CHAIN ANALYSIS 52
7 BIOBURDEN TESTING MARKET, BY PRODUCT 54
7.1 INTRODUCTION 55
7.2 CONSUMABLES 56
7.2.1 CULTURE MEDIA, REAGENTS, & KITS 59
7.2.2 OTHER CONSUMABLES 60
7.3 INSTRUMENTS 61
7.3.1 PCR 63
7.3.2 MICROSCOPES 64
7.3.3 AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS 66
7.3.4 OTHER INSTRUMENTS 67
8 BIOBURDEN TESTING MARKET, BY TEST TYPE 69
8.1 INTRODUCTION 70
8.2 AEROBIC COUNT 71
8.3 ANAEROBIC COUNT 72
8.4 FUNGI/MOLD COUNT 73
8.5 SPORE COUNT 74
9 BIOBURDEN TESTING MARKET, BY APPLICATION 76
9.1 INTRODUCTION 77
9.2 RAW MATERIALS TESTING 78
9.3 MEDICAL DEVICES TESTING 79
9.4 IN-PROCESS MATERIAL TESTING 80
9.5 STERILIZATION VALIDATION TESTING 81
9.6 EQUIPMENT CLEANING VALIDATION 83
10 BIOBURDEN TESTING MARKET, BY END USER 84
10.1 INTRODUCTION 85
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 86
10.3 MEDICAL DEVICE MANUFACTURERS 88
10.4 CONTRACT MANUFACTURING ORGANIZATIONS 89
10.5 MANUFACTURERS OF FOOD & BEVERAGE AND AGRICULTURAL PRODUCTS 91
10.6 MICROBIAL TESTING LABORATORIES 92
11 GEOGRAPHIC ANALYSIS 94
11.1 INTRODUCTION 95
11.2 NORTH AMERICA 97
11.2.1 U.S. 102
11.2.2 CANADA 105
11.3 EUROPE 108
11.4 ASIA 111
11.5 REST OF THE WORLD (ROW) 115
12 COMPETITIVE LANDSCAPE 119
12.1 OVERVIEW 119
12.2 COMPETITIVE SITUATION AND TRENDS 120
12.2.1 ACQUISITIONS 121
12.2.2 NEW PRODUCT AND SERVICE LAUNCHES 121
12.2.3 EXPANSIONS 122
12.2.4 OTHERS 122
13 COMPANY PROFILES 123
13.1 INTRODUCTION 123
13.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 124
13.2.1 BUSINESS OVERVIEW 124
13.2.2 PRODUCTS & SERVICES 125
13.2.3 RECENT DEVELOPMENTS 125
13.2.4 MNM VIEW 125
13.3 SIGMA-ALDRICH CORPORATION 126
13.3.1 BUSINESS OVERVIEW 126
13.3.2 PRODUCTS & SERVICES 127
13.3.3 RECENT DEVELOPMENTS 127
13.3.4 MNM VIEW 127
13.4 SGS S.A. 128
13.4.1 BUSINESS OVERVIEW 128
13.4.2 SERVICES 129
13.4.3 MNM VIEW 129
13.5 WUXI PHARMATECH (CAYMAN), INC. 130
13.5.1 BUSINESS OVERVIEW 130
13.5.2 SERVICES 131
13.5.3 MNM VIEW 131
13.6 MERCK & CO., INC. 132
13.6.1 BUSINESS OVERVIEW 132
13.6.2 PRODUCTS & SERVICES 133
13.6.3 RECENT DEVELOPMENTS 133
13.6.4 MNM VIEW 134
13.7 BECTON, DICKINSON, AND COMPANY 135
13.7.1 BUSINESS OVERVIEW 135
13.7.2 PRODUCT & SERVICES 136
13.7.3 KEY STRATEGY 136
13.8 NORTH AMERICAN SCIENCE ASSOCIATES, INC. (NAMSA) 137
13.8.1 BUSINESS OVERVIEW 137
13.8.2 SERVICES 137
13.8.3 KEY STRATEGY 137
13.8.4 RECENT DEVELOPMENTS 137
13.9 NELSON LABORATORIES, INC. 138
13.9.1 BUSINESS OVERVIEW 138
13.9.2 SERVICES 138
13.9.3 KEY STRATEGY 138
13.9.4 RECENT DEVELOPMENTS 138
13.10 PACIFIC BIOLABS 139
13.10.1 BUSINESS OVERVIEW 139
13.10.2 SERVICE PORTFOLIO 139
13.10.3 KEY STRATEGY 139
13.11 ATS LABS, INC. 140
13.11.1 BUSINESS OVERVIEW 140
13.11.2 SERVICES 140
13.11.3 KEY STRATEGY 140
13.11.4 RECENT DEVELOPMENTS 140
14 APPENDIX 141
14.1 INSIGHTS FROM INDUSTRY EXPERTS 141
14.2 DISCUSSION GUIDE 142
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144
14.4 AVAILABLE CUSTOMIZATIONS 144
14.5 RELATED REPORTS 145
“
“LIST OF TABLES
TABLE 1 GROWTH IN PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICES INDUSTRIES TO DRIVE THE GROWTH OF BIOBURDEN TESTING MARKET 46
TABLE 2 HIGH COST OF INSTRUMENTS WILL HINDER MARKET GROWTH 47
TABLE 3 CONTRACT MANUFACTURING TO CREATE NEW GROWTH OPPORTUNITIES FOR MARKET 48
TABLE 4 LACK OF SKILLED EXPERTS A MAJOR CHALLENGE FOR MARKET GROWTH 49
TABLE 5 BIOBURDEN TESTING MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 56
TABLE 6 BIOBURDEN TESTING MARKET SIZE FOR CONSUMABLES, BY TYPE,
2012-2019 ($MILLION) 57
TABLE 7 BIOBURDEN TESTING MARKET SIZE FOR CONSUMABLES, BY REGION,
2012-2019 ($MILLION) 58
TABLE 8 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR CONSUMABLES,
BY COUNTRY, 2012-2019 ($MILLION) 58
TABLE 9 BIOBURDEN TESTING MARKET SIZE FOR CULTURE MEDIA, REAGENTS, & KITS,
BY REGION, 2012-2019 ($MILLION) 59
TABLE 10 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR CULTURE MEDIA, REAGENTS, & KITS, BY COUNTRY, 2012-2019 ($MILLION) 59
TABLE 11 BIOBURDEN TESTING MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2012-2019 ($MILLION) 60
TABLE 12 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR OTHER CONSUMABLES, BY COUNTRY, 2012-2019 ($MILLION) 60
TABLE 13 BIOBURDEN TESTING MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2012-2019 ($MILLION) 62
TABLE 14 BIOBURDEN TESTING MARKET SIZE FOR INSTRUMENTS, BY REGION,
2012-2019 ($MILLION) 62
TABLE 15 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR INSTRUMENTS,
BY COUNTRY, 2012-2019 ($MILLION) 63
TABLE 16 BIOBURDEN TESTING MARKET SIZE FOR PCR, BY REGION, 2012-2019 ($MILLION) 63
TABLE 17 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR PCR, BY COUNTRY, 2012-2019 ($MILLION) 64
TABLE 18 BIOBURDEN TESTING MARKET SIZE FOR MICROSCOPES, BY REGION,
2012-2019 ($MILLION) 65
TABLE 19 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR MICROSCOPES,
BY COUNTRY, 2012-2019 ($MILLION) 65
TABLE 20 BIOBURDEN TESTING MARKET SIZE FOR AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS, BY REGION, 2012-2019 ($MILLION) 66
TABLE 21 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS, BY COUNTRY, 2012-2019 ($MILLION) 67
TABLE 22 BIOBURDEN TESTING MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION, 2012-2019 ($MILLION) 67
TABLE 23 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR OTHER INSTRUMENTS, BY COUNTRY, 2012-2019 ($MILLION) 68
TABLE 24 BIOBURDEN TESTING MARKET SIZE, BY TEST 2012–2019 ($MILLION) 71
TABLE 25 BIOBURDEN TESTING MARKET SIZE FOR AEROBIC COUNT, BY REGION,
2012-2019 ($MILLION) 71
TABLE 26 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR AEROBIC COUNT,
BY COUNTRY, 2012-2019 ($MILLION) 72
TABLE 27 BIOBURDEN TESTING MARKET SIZE FOR ANAEROBIC COUNT, BY REGION,
2012–2019 ($MILLION) 72
TABLE 28 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR ANAEROBIC COUNT,
BY COUNTRY, 2012–2019 ($MILLION) 73
TABLE 29 BIOBURDEN TESTING MARKET SIZE FOR FUNGI/MOLD COUNT, BY REGION, 2012–2019 ($MILLION) 73
TABLE 30 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR FUNGI/MOLD COUNT, BY COUNTRY, 2012–2019 ($MILLION) 74
TABLE 31 BIOBURDEN TESTING MARKET SIZE FOR SPORE COUNT, BY REGION,
2012–2019 ($MILLION) 74
TABLE 32 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR SPORE COUNT,
BY COUNTRY, 2012–2019 ($MILLION) 75
TABLE 33 BIOBURDEN TESTING MARKET SIZE, BY APPLICATION 2012–2019 ($MILLION) 78
TABLE 34 BIOBURDEN TESTING MARKET SIZE FOR RAW MATERIALS TESTING, BY REGION, 2012-2019 ($MILLION) 78
TABLE 35 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR RAW MATERIALS TESTING, BY COUNTRY, 2012-2019 ($MILLION) 79
TABLE 36 BIOBURDEN TESTING MARKET SIZE FOR MEDICAL DEVICES TESTING, BY REGION, 2012-2019 ($MILLION) 79
TABLE 37 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR MEDICAL DEVICES TESTING, BY COUNTRY, 2012-2019 ($MILLION) 80
TABLE 38 BIOBURDEN TESTING MARKET SIZE FOR IN-PROCESS TESTING, BY REGION,
2012-2019 ($MILLION) 80
TABLE 39 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR IN-PROCESS TESTING, BY COUNTRY, 2012-2019 ($MILLION) 81
TABLE 40 BIOBURDEN TESTING MARKET SIZE FOR STERILIZATION VALIDATION TESTING,
BY REGION, 2012-2019 ($MILLION) 82
TABLE 41 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR STERILIZATION VALIDATION TESTING, BY COUNTRY, 2012-2019 ($MILLION) 82
TABLE 42 BIOBURDEN TESTING MARKET SIZE FOR EQUIPMENT CLEANING VALIDATION,
BY REGION, 2012-2019 ($MILLION) 83
TABLE 43 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR EQUIPMENT CLEANING VALIDATION , BY COUNTRY, 2012-2019 ($MILLION) 83
TABLE 44 GLOBAL BIOBURDEN TESTING MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 86
TABLE 45 GLOBAL BIOBURDEN TESTING MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2012–2019 ($MILLION) 87
TABLE 46 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2012–2019 ($MILLION) 87
TABLE 47 GLOBAL BIOBURDEN TESTING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2012–2019 ($MILLION) 88
TABLE 48 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2012–2019 ($MILLION) 88
TABLE 49 GLOBAL BIOBURDEN TESTING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2012–2019 ($MILLION) 90
TABLE 50 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2012–2019 ($MILLION) 90
TABLE 51 GLOBAL BIOBURDEN TESTING MARKET SIZE FOR MANUFACTURERS OF FOOD & BEVERAGE AND AGRICULTURAL PRODUCTS, BY REGION, 2012–2019 ($MILLION) 91
TABLE 52 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR MANUFACTURERS OF FOOD & BEVERAGE AND AGRICULTURAL PRODUCTS, BY COUNTRY,
2012–2019 ($MILLION) 92
TABLE 53 GLOBAL BIOBURDEN TESTING MARKET SIZE FOR MICROBIAL TESTING LABS,
BY REGION, 2012–2019 ($MILLION) 92
TABLE 54 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE FOR MICROBIAL TESTING LABS, BY COUNTRY, 2012–2019 ($MILLION) 93
TABLE 55 BIOBURDEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 96
TABLE 56 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 99
TABLE 57 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 99
TABLE 58 NORTH AMERICA: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 99
TABLE 59 NORTH AMERICA: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 100
TABLE 60 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 100
TABLE 61 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 101
TABLE 62 NORTH AMERICA: BIOBURDEN TESTING MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 101
TABLE 63 U.S.: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 102
TABLE 64 U.S.: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 103
TABLE 65 U.S.: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 103
TABLE 66 U.S.: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE, 2012–2019 ($MILLION) 104
TABLE 67 U.S.: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 104
TABLE 68 U.S.: BIOBURDEN TESTING MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 105
TABLE 69 CANADA: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 105
TABLE 70 CANADA: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 106
TABLE 71 CANADA: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 106
TABLE 72 CANADA: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 107
TABLE 73 CANADA: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 107
TABLE 74 CANADA: BIOBURDEN TESTING MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 108
TABLE 75 EUROPE: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 109
TABLE 76 EUROPE: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 109
TABLE 77 EUROPE: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 109
TABLE 78 EUROPE: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 110
TABLE 79 EUROPE: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 110
TABLE 80 EUROPE: BIOBURDEN TESTING MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 111
TABLE 81 ASIA: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 112
TABLE 82 ASIA: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 113
TABLE 83 ASIA: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 113
TABLE 84 ASIA: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE, 2012–2019 ($MILLION) 114
TABLE 85 ASIA: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 114
TABLE 86 ASIA: BIOBURDEN TESTING MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 115
TABLE 87 ROW: BIOBURDEN TESTING MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 116
TABLE 88 ROW: BIOBURDEN TESTING CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 116
TABLE 89 ROW: BIOBURDEN TESTING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 116
TABLE 90 ROW: BIOBURDEN TESTING MARKET SIZE, BY TEST TYPE, 2012–2019 ($MILLION) 117
TABLE 91 ROW: BIOBURDEN TESTING MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 117
TABLE 92 ROW: BIOBURDEN TESTING MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 118
TABLE 93 RECENT ACQUISITIONS 121
TABLE 94 RECENT PRODUCT AND SERVICE LAUNCHES 122
TABLE 95 RECENT EXPANSIONS 122
TABLE 96 RECENT OTHER STRATEGIES 122
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 TOP-DOWN APPROACH 21
FIGURE 3 BOTTOM-UP APPROACH 22
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 5 CONSUMABLES SEGMENT TO DOMINATE THE BIOBURDEN TESTING PRODUCTS MARKET DURING THE FORECAST PERIOD 26
FIGURE 6 AEROBIC COUNT SEGMENT TO WITNESS HIGHEST GROWTH RATE FROM
2014 TO 2019 27
FIGURE 7 BIOBURDEN TESTING MARKET SNAPSHOT, BY APPLICATION (2014 VS. 2019): RAW MATERIAL TESTING SEGMENT WILL CONTINUE TO DOMINATE THE BIOBURDEN TESTING MARKET IN THE FORECAST PERIOD 28
FIGURE 8 THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES END-USER SEGMENT DOMINATED THE MARKET IN 2014 29
FIGURE 9 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE BIOBURDEN TESTING MARKET IN 2014 30
FIGURE 10 ACQUISITIONS AND NEW PRODUCT & SERVICE LAUNCHES WERE THE PREFERRED GROWTH STRATEGIES FOR MARKET PLAYERS 31
FIGURE 11 CONSUMABLES SEGMENT TO GROW AT A HIGH RATE 32
FIGURE 12 PCR SEGMENT TO WITNESS HIGHEST GROWTH RATE IN THE INSTRUMENTS MARKET 33
FIGURE 13 CULTURE MEDIA AND REAGENTS & KITS TO DOMINATE THE CONSUMABLES MARKET 34
FIGURE 14 AEROBIC COUNT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD 35
FIGURE 15 RAW MATERIAL TESTING ACCOUNTED FOR THE LARGEST SHARE OF THE BIOBURDEN TESTING MARKET IN 2014 36
FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 37
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST END-USER SEGMENT 38
FIGURE 18 BIOBURDEN TESTING MARKET SEGMENTATION, BY PRODUCT 40
FIGURE 19 BIOBURDEN TESTING MARKET SEGMENTATION, BY TEST TYPE 41
FIGURE 20 BIOBURDEN TESTING MARKET SEGMENTATION, BY APPLICATION 41
FIGURE 21 BIOBURDEN TESTING MARKET SEGMENTATION, BY END USER 42
FIGURE 22 BIOBURDEN TESTING MARKET SEGMENTATION, BY REGION 42
FIGURE 23 GROWTH IN MEDICAL DEVICES, PHARMACEUTICAL, AND BIOTECHNOLOGY INDUSTRIES TO FUEL MARKET GROWTH 43
FIGURE 24 GLOBAL HEALTHCARE SPENDING, BY REGION 2003-2012 45
FIGURE 25 PORTER’S FIVE FORCES ANALYSIS 50
FIGURE 26 STRATEGIC BENCHMARKING: TOP PLAYERS ADOPTED ACQUISITION AS A KEY GROWTH STRATEGY 52
FIGURE 27 SUPPLY CHAIN: DISTRIBUTION THROUGH SERVICE PROVIDERS IS MOST PREFERRED STRATEGY FOLLOWED BY PROMINENT MARKET PLAYERS 53
FIGURE 28 CONSUMABLES MARKET TO WITNESS SIGNIFICANT GROWTH IN THE FORECAST PERIOD 55
FIGURE 29 ASIA TO RECORD THE HIGHEST GROWTH RATE IN THE CONSUMABLES MARKET 57
FIGURE 30 BIOBURDEN TESTING INSTRUMENTS MARKET IN ASIA WILL GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 61
FIGURE 31 AEROBIC COUNT SEGMENT TO WITNESS SIGNIFICANT GROWTH IN THE
FORECAST PERIOD 70
FIGURE 32 RAW MATERIALS TESTING SEGMENT TO WITNESS GROWTH IN THE FORECAST PERIOD 77
FIGURE 33 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD HIGHEST MARKET SHARE IN THE FORECAST PERIOD 85
FIGURE 34 ASIA TO GROW AT THE HIGHEST CAGR FOR CONTRACT MANUFACTURING ORGANIZATIONS 89
FIGURE 35 ASIAN BIOBURDEN TESTING MARKET EXPECTED TO GROW AT THE HIGHEST RATE 95
FIGURE 36 ASIA: HIGH DEMAND FOR BIOBURDEN TESTING FROM 2014 TO 2019 96
FIGURE 37 NORTH AMERICA: MARKET SNAPSHOT 98
FIGURE 38 MAJOR PLAYERS ADOPTED ACQUISITIONS AND NEW PRODUCT AND SERVICE LAUNCHES AS A KEY GROWTH STRATEGY BETWEEN 2012 AND 2014 119
FIGURE 39 MARKET EVOLUTION FRAMEWORK: ACQUISITIONS AND PRODUCT AND SERVICE LAUNCHES FUELLED MARKET GROWTH 120
FIGURE 40 ACQUISITIONS, NEW PRODUCT AND SERVICE LAUNCHES WERE PREFERRED STRATEGIES FOR MARKET PLAYERS 120
FIGURE 41 GEOGRAPHIC REVENUE MIX OF TOP 4 MARKET PLAYERS 123
FIGURE 42 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT 124
FIGURE 43 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 126
FIGURE 44 SGS SA: COMPANY SNAPSHOT 128
FIGURE 45 WUXI PHARMATECH (CAYMAN) INC.: COMPANY SNAPSHOT 130
FIGURE 46 MERCK & CO., INC.: COMPANY SNAPSHOT 132
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 135
“
